News Focus
News Focus
icon url

Castratrix

03/09/20 12:03 PM

#17323 RE: badbass58 #17322

lol, and who the hell is citron research? sounds like some housedaddy that is suicidally short.
icon url

Hey Ray

03/09/20 12:05 PM

#17324 RE: badbass58 #17322

Lol BS .. CITRON LOL they are short sellers
icon url

Biotech Investr

03/09/20 12:11 PM

#17331 RE: badbass58 #17322

Maxim analyst Jason McCarthy, Ph.D., said Inovio likely has the best vaccine option for the new illness.


https://www.marketwatch.com/story/inovio-shares-rally-after-biotech-says-human-trials-of-coronavirus-vaccine-will-start-in-april-2020-03-03
icon url

Castratrix

03/09/20 12:15 PM

#17333 RE: badbass58 #17322

lol, and who the hell is citron research? that entire tweet sounds like some housedaddy that is suicidally short.
icon url

Scruffer

03/09/20 12:19 PM

#17334 RE: badbass58 #17322

They must've been SHORT at $4. LOL.

And they said a new popular bike company should be $5 in December.

It's still around $25 per share.

Look it up. I think the subscription rate was around $39/month.

Fear, Uncertainty & Doubt (FUD) isn't going to work here.

Moreover, with today's huge sell-off, some leverage funds may need to raise capital. They can always buy back in since a year+ out.

https://abcnews.go.com/Health/wireStory/scenes-scientists-prep-covid-19-vaccine-test-69467049

Scruffer